The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
This Guidelines summary covers guidance for safe video consulting in general practice. It includes key principles, general information, and recommendations on conducting safe video consultations. Refer to the full guideline for information on:
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
This Guidelines summary outlines standard operating procedures for general practices in the context of COVID-19.
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic.
This summary is intended to aid primary healthcare practitioners in initiating, reviewing, and prescribing hormone replacement therapy for women during COVID-19.
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
This guideline aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic